In many Balb/c mouse myeloma cell lines the c-myc oncogene normally located on chromosome 15 is often translocated to a H chain constant region locus on chromosome 12. In the majority of myelomas studied, the translocation of c-myc is to the alpha constant region sequence (C-alpha) of the H chain """"""""non-productive"""""""" gene (the mRNA coding strand of DNA for the c-myc gene is on the anti-sense strand for the C-alpha gene). While unrearranged C-alpha alleles are transcriptionally silent, C-alpha genes to which the c-myc oncogene has translocated are transcriptionally active. Several discrete cytoplasmic RNA species hybridizing to a alpha-C region probe can be detected. Some of these appear to be transcribed from the C-alpha sense strand. In a mouse myeloma MOPC 315 variant line (V-1), which has lost the alpha-H chain gene, cotranscription of c-myc and C-alpha sequences has been detected. In this application the products of the c-myc-C-alpha transcriptional unit in V-1 cells will be examined. A genomic clone of this locus has been isolated. The initiation and termination sites will be mapped, and the products of transcription analyzed. The sizes of C-alpha and c-myc proteins will be determined using hybrid-selection and cell-free translation in a rabbit reticulocyte system. The steps in synthesis and processing of C-alpha proteins will be determined. Finally, the possible relationship of the translocation of c-myc to C-alpha to the loss of normal immunosuppression of cell growth will be studied. Methods will include tissue culture, RNA and DNA blot hybridization, DNA sequencing, cell-free translation, and acrylamide and agarose gel electrophoresis. The experiments will characterize the RNA and protein products of the c-myc oncogene-C-alpha gene locus and help define their possible roles in the neoplastic transformation of myeloma cells. (X)

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA036355-03
Application #
3173905
Study Section
Mammalian Genetics Study Section (MGN)
Project Start
1984-01-01
Project End
1986-12-31
Budget Start
1986-01-01
Budget End
1986-12-31
Support Year
3
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Boston University
Department
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Wang, Xiaobo; Belguise, Karine; O'Neill, Christine F et al. (2009) RelB NF-kappaB represses estrogen receptor alpha expression via induction of the zinc finger protein Blimp1. Mol Cell Biol 29:3832-44
Chandramohan, Vidyalakshmi; Mineva, Nora D; Burke, Brian et al. (2008) c-Myc represses FOXO3a-mediated transcription of the gene encoding the p27(Kip1) cyclin dependent kinase inhibitor. J Cell Biochem 104:2091-106
Wang, Xiaobo; Belguise, Karine; Kersual, Nathalie et al. (2007) Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2. Nat Cell Biol 9:470-8
Mineva, Nora D; Rothstein, Thomas L; Meyers, John A et al. (2007) CD40 ligand-mediated activation of the de novo RelB NF-kappaB synthesis pathway in transformed B cells promotes rescue from apoptosis. J Biol Chem 282:17475-85
Chandramohan, Vidyalakshmi; Jeay, Sebastien; Pianetti, Stefania et al. (2004) Reciprocal control of Forkhead box O 3a and c-Myc via the phosphatidylinositol 3-kinase pathway coordinately regulates p27Kip1 levels. J Immunol 172:5522-7
Guo, Shangqin; Sonenshein, Gail E (2004) Forkhead box transcription factor FOXO3a regulates estrogen receptor alpha expression and is repressed by the Her-2/neu/phosphatidylinositol 3-kinase/Akt signaling pathway. Mol Cell Biol 24:8681-90
Arsura, Marcello; Panta, Ganesh R; Bilyeu, Jennifer D et al. (2003) Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation. Oncogene 22:412-25
Jiang, H Y; Petrovas, Constantinos; Sonenshein, Gail E (2002) RelB-p50 NF-kappa B complexes are selectively induced by cytomegalovirus immediate-early protein 1: differential regulation of Bcl-x(L) promoter activity by NF-kappa B family members. J Virol 76:5737-47
Yang, W; Shen, J; Wu, M et al. (2001) Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc. Oncogene 20:1688-702
Jeay, S; Sonenshein, G E; Kelly, P A et al. (2001) Growth hormone exerts antiapoptotic and proliferative effects through two different pathways involving nuclear factor-kappaB and phosphatidylinositol 3-kinase. Endocrinology 142:147-56

Showing the most recent 10 out of 56 publications